Home DailyMed af63f276-3b51-41cf-9775-31eaa4b563f1 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2013-02-13
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 03:20:29
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021539-001 ACETADOTE ACETYLCYSTEINE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021539-001 AP
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021539-001 8148356 2026-05-21 Drug product 2012-04-04 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 N021539-001 8722738 2032-04-06 U-1373 2014-05-27
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N021539-001 D-196 2027-11-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 c2088c7a36db…2026-09-14 22:38:34 2026-08 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N021539-001 ACETADOTE 6GM/30ML (200MG/ML) INJECTABLE / INTRAVENOUS AP RLD, RS 2004-01-23 3a93d1ddd44b…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
Observed Orange Book patent history# Patent history page 1 of 6 · 210 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 c2088c7a36db…2026-09-14 22:38:34 2026-08 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021539-001 8399445 2025-08-24 U-1373 2013-03-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021539-001 8653061 2025-08-24 U-1373 2014-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021539-001 8399445 2025-08-24 U-1373 2013-03-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021539-001 8653061 2025-08-24 U-1373 2014-02-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021539-001 8399445 2025-08-24 U-1373 2013-03-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021539-001 8653061 2025-08-24 U-1373 2014-02-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021539-001 8399445 2025-08-24 U-1373 2013-03-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021539-001 8653061 2025-08-24 U-1373 2014-02-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021539-001 8399445 2025-08-24 U-1373 2013-03-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021539-001 8653061 2025-08-24 U-1373 2014-02-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021539-001 9327028 2031-07-21 U-1839 2016-05-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021539-001 8722738 2032-04-06 U-1373 2014-05-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021539-001 8399445 2025-08-24 U-1373 2013-03-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021539-001 8653061 2025-08-24 U-1373 2014-02-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021539-001 8148356 2026-05-21 Drug product 2012-04-04 2680178bc6a6…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-10-15 13:18:30 2026-09 N021539-001 D-196 2027-11-26 c2088c7a36db…2026-09-14 22:38:34 2026-08 N021539-001 D-196 2027-11-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021539-001 D-196 2027-11-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021539-001 D-196 2027-11-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021539-001 D-196 2027-11-26 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021539-001 D-196 2027-11-26 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.